Correlation Between Agilent Technologies and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Agilent Technologies and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and Pmv Pharmaceuticals.
Diversification Opportunities for Agilent Technologies and Pmv Pharmaceuticals
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Agilent and Pmv is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Agilent Technologies and Pmv Pharmaceuticals
Taking into account the 90-day investment horizon Agilent Technologies is expected to generate 0.58 times more return on investment than Pmv Pharmaceuticals. However, Agilent Technologies is 1.73 times less risky than Pmv Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest 13,384 in Agilent Technologies on September 23, 2024 and sell it today you would earn a total of 67.00 from holding Agilent Technologies or generate 0.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Agilent Technologies vs. Pmv Pharmaceuticals
Performance |
Timeline |
Agilent Technologies |
Pmv Pharmaceuticals |
Agilent Technologies and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Agilent Technologies and Pmv Pharmaceuticals
The main advantage of trading using opposite Agilent Technologies and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.Agilent Technologies vs. Twist Bioscience Corp | Agilent Technologies vs. Natera Inc | Agilent Technologies vs. Guardant Health | Agilent Technologies vs. Castle Biosciences |
Pmv Pharmaceuticals vs. Fate Therapeutics | Pmv Pharmaceuticals vs. Sana Biotechnology | Pmv Pharmaceuticals vs. Caribou Biosciences | Pmv Pharmaceuticals vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |